BYON Co., Ltd.

A032980

KR7032980005

Food Processing

End-of-day quote Korea S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
1,021 ^KRW	+7.59%		+16.15%	-20.23%

05-17	BYON Co., Ltd. announced that it has received KRW 10.5 billion in funding	CI
03-07	CTM Co. Ltd. and Byeong-cheol Jeon agreed to acquire 28% stake in Kwang Jin Ind. Co., Ltd. from BYON Co., Ltd. for KRW 6 billion.	CI

BYON Co., Ltd. announced that it has received KRW 2.999999085 billion in funding from Mirae Cell Bio Co., Ltd.

May 10, 2018

On May 11, 2018, BYON Co., Ltd. (KOSDAQ:A032980) closed the transaction.

Latest news about BYON Co., Ltd.

BYON Co., Ltd. announced that it has received KRW 10.5 billion in funding	05-16	CI
CTM Co. Ltd. and Byeong-cheol Jeon agreed to acquire 28% stake in Kwang Jin Ind. Co., Ltd. from BYON Co., Ltd. for KRW 6 billion.	03-06	CI
BYON Co., Ltd. announced that it expects to receive KRW 6.999999023 billion in funding	11-12	CI
CTM Co. Ltd. agreed to acquire a 9.37% stake in BYON Co., Ltd. from W Global 1 Union and Kim Byeong Jun for KRW 11.9 billion	11-12	CI
BYON Co., Ltd. amended terms of the transaction	17/10/23	CI
BYON Co., Ltd. cancelled the transaction announced on August 2, 2023	17/10/23	CI
BYON Co., Ltd. announced that it expects to receive KRW 20 billion in funding	07/10/23	CI
I-World Pharm Co., Ltd. cancelled the acquisition of 10.56% stake in BYON Co., Ltd. from W Global 1 Union and Byungjun Kim.	24/09/23	CI
ByOn Plans 7 Billion Won Stock Sale	03/08/23	MT
BYON Co., Ltd. announced that it expects to receive KRW 6.999999 billion in funding from I-World Pharm Co., Ltd.	01/08/23	CI
I-World Pharm Co., Ltd. agreed to acquire a 10.56% stake in BYON Co., Ltd. from W Global 1 Union and Byungjun Kim for KRW 13.7 billion	01/08/23	CI
BYON Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23	CI
BYON Co., Ltd. announced that it has received KRW 1.5 billion in funding from Fortress Investment	02/03/23	CI
BYON Co., Ltd. announced that it expects to receive KRW 1.5 billion in funding from Fortress Investment	27/02/23	CI
BYON Co., Ltd. announced that it has received KRW 8 billion in funding from Hands Partners Co., Ltd., Eugene Investment & Securities Co.,Ltd. and other investors	03/06/21	CI
BYON Co., Ltd. announced that it expects to receive KRW 8 billion in funding from Hands Partners Co., Ltd., Eugene Investment & Securities Co.,Ltd. and other investors	01/06/21	CI
BYON Co., Ltd. announced that it has received KRW 4.99999959 billion in funding	07/04/21	CI
BYON Co., Ltd. announced that it expects to receive KRW 4.99999959 billion in funding	15/09/20	CI
BYON Co., Ltd. acquired 50% stake in Anti-Aging Co., Ltd. from Nonaka Hidenori for KRW 1.5 billion.	27/03/19	CI
NANOMEDICS Co., Ltd. acquired 4.8% stake in BYON Co., Ltd. for KRW 3.0 billion.	04/12/18	CI
BYON Co., Ltd. announced that it has received KRW 2 billion in funding	10/10/18	CI
BYON Co., Ltd. announced that it expects to receive KRW 2 billion in funding	01/10/18	CI
BYON Co., Ltd. announced that it has received KRW 2.999999085 billion in funding from Mirae Cell Bio Co., Ltd.	10/05/18	CI
BYON Co., Ltd. announced that it expects to receive KRW 2.999999085 billion in funding from Mirae Cell Bio Co., Ltd.	11/04/18	CI
BYON Co., Ltd. acquired Cosmetic Standard Co., Ltd. from Sangsun Jung and Myunghwan park for KRW 8 billion.	04/04/18	CI

BYON Co., Ltd., formerly Polyvision Co., Ltd is a Korea-based company primarily engaged in the manufacture and distribution of industrial materials. The Company operates its business through three segments. Its Industrial Material segment manufactures tarpaulins, banner flexes and polyvinyl chloride (PVC) flooring materials, which are used for truck covers, roof covers, billboards, flags, container bags and house decoration tiles. Its Overseas Resources Development segment explores copper and molybdenum. Its Bio Medical segment sells medicines and medical equipment. The Company distributes its products within domestic market and to overseas markets.

Sector

Food Processing

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
BYON CO., LTD.	-20.23%	30.56M
ZHEJIANG NHU COMPANY LTD.	+16.86%	8.43B
BELLRING BRANDS, INC.	+3.57%	7.49B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+4.89%	6.23B
THE SIMPLY GOOD FOODS COMPANY	-5.23%	3.75B
BYHEALTH CO., LTD	-6.58%	3.75B
XIAMEN KINGDOMWAY GROUP COMPANY	-3.55%	1.33B
HERBALIFE LTD.	-28.64%	1.09B
SIRIO PHARMA CO., LTD.	+18.12%	1.02B
USANA HEALTH SCIENCES, INC.	-8.60%	933M